Resultados de procura - Arndt Vogel

Limitar resultados
  1. 1
    Autoimmune Hepatitis, From Mechanisms to Therapy

    Autoimmune Hepatitis, From Mechanisms to Therapy por Michael P. Manns, Arndt Vogel

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Epidemiology and Risk Factors of Cholangiocarcinoma

    Epidemiology and Risk Factors of Cholangiocarcinoma por Martha M. Kirstein, Arndt Vogel

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next?

    FGFR inhibitors in cholangiocarcinoma: what’s now and what’s next? por Anna Saborowski, Ulrich Lehmann, Arndt Vogel

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

    Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis por Arndt Vogel, Christian P. Strassburg, Michael P. Manns

    Publicado 2002
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    FGFR2 Inhibition in Cholangiocarcinoma

    FGFR2 Inhibition in Cholangiocarcinoma por Arndt Vogel, Oreste Segatto, Albrecht Stenzinger, Anna Saborowski

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies

    Treatment decisions in metastatic colorectal cancer – Beyond first and second line combination therapies por Arndt Vogel, Ralf‐Dieter Hofheinz, Stefan Kubicka, Dirk Arnold

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    The Diagnosis and Treatment of Cholangiocarcinoma

    The Diagnosis and Treatment of Cholangiocarcinoma por Arndt Vogel, Henning Wege, Karel Caca, Björn Nashan, Ulf P. Neumann

    Publicado 2014
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice

    Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice por Ângelo Zambam de Mattos, Isadora Bombassaro, Arndt Vogel, José D. Debes

    Publicado 2024
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab

    Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab por Chiun Hsu, Lorenza Rimassa, Hui‐Chuan Sun, Arndt Vogel, Ahmed O. Kaseb

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma

    Charting co-mutation patterns associated with actionable drivers in intrahepatic cholangiocarcinoma por Gajanan Kendre, Karthikeyan Murugesan, Tilman Brummer, Oreste Segatto, Anna Saborowski, Arndt Vogel

    Publicado 2022
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Systemic Therapy of Advanced Hepatocellular Carcinoma

    Systemic Therapy of Advanced Hepatocellular Carcinoma por Peter R. Galle, Jean‐François Dufour, Markus Peck‐Radosavljevic, Jörg Trojan, Arndt Vogel

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer

    UDP glucuronosyltransferase (UGT1A7) gene polymorphisms increase the risk of chronic pancreatitis and pancreatic cancer por Johann Ockenga, Arndt Vogel, Niels Teich, Volker Keim, Michael P. Manns, Christian P. Strassburg

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data

    Targeted Therapies in Metastatic Colorectal Cancer: A Systematic Review and Assessment of Currently Available Data por Martha M. Kirstein, Ansgar Lange, Anne Prenzler, Michael P. Manns, Stefan Kubicka, Arndt Vogel

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  14. 14
    Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing

    Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing por Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, Ángela Lamarca, Paul Hofman, Luigi Terracciano, Nicola Normanno

    Publicado 2023
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4

    Variation of hepatic glucuronidation: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4 por Ursula Ehmer, Arndt Vogel, Jan Karl Schütte, B Krone, Michael P. Manns, Christian P. Strassburg

    Publicado 2004
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Next-Generation Biomarkers for Cholangiocarcinoma

    Next-Generation Biomarkers for Cholangiocarcinoma por Pedro M. Rodrigues, Arndt Vogel, Marco Arrese, Domingo Balderramo, Juan W. Valle, Jesús M. Bañales

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy

    Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy por Ângelo Zambam de Mattos, José D. Debes, André Boonstra, Arndt Vogel, Ângelo Alves de Mattos

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  18. 18
    Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up por Florian Lordick, Fátima Carneiro, Stefano Cascinu, Tania Fleitas, Karin Haustermans, Guillaume Piessen, Arndt Vogel, Elizabeth Smyth

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

    Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines por Arndt Vogel, Erika Martinelli, Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli

    Publicado 2021
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer

    A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancer por Ansgar Lange, Anne Prenzler, Martin Frank, Martha M. Kirstein, Arndt Vogel, Johann‐Matthias Graf von der Schulenburg

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: